D&D Pharmatech Inc. (KOSDAQ: A347850)
Health Care · Biotechnology · KR
₩42,850.00
-0.35% today · -8.0% 1Y
D&D Pharmatech Inc. (KOSDAQ: A347850) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.46B.
Over the last twelve months the share price has lost 8.0%, trading between 39.95K and 116.60K.
Tweenvest scores D&D Pharmatech Inc. across four factors: quality 42/100, value 41/100. Its strongest factor is quality.
A347850 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.46B
- Revenue (TTM)
- $1.78M
- P/E
- —
- EPS
- -824.34
- Dividend yield
- —
- Beta (5Y)
- 1.73
- 52-week high
- ₩116,600.00
- 52-week low
- ₩39,950.00
- Avg volume (3M)
- —
- Shares outstanding
- 45.84M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| InventisBio Co., LimitedSHSE: 688382 | $1.49B | CN¥17.26 | -9.49% |
| Staidson (Beijing) BioPharmaceuticals Co., Ltd.SZSE: 300204 | $1.47B | CN¥20.66 | +1.08% |
| Hugel, Inc.KOSDAQ: A145020 | $1.47B | ₩182,800.00 | +1.50% |
| Taysha Gene Therapies, Inc.NasdaqGS: TSHA | $1.46B | $4.17 | -7.24% |
| Bonesupport Holding AB (publ)OM: BONEX | $1.45B | Skr242.60 | +8.98% |
| Nektar TherapeuticsNasdaqCM: NKTR | $1.41B | $39.72 | -3.52% |
| Inhibrx Biosciences, Inc.NasdaqGS: INBX | $1.40B | $91.97 | -3.20% |
| Pacific Shuanglin Bio-pharmacy Co., Ltd.SZSE: 000403 | $1.39B | CN¥9.96 | -0.99% |
Figures last refreshed Oct 11, 2026.